« Previous
Next »
Titles
- AMX0035 and oral edaravone for amyotrophic lateral sclerosis: final evidence report1
- Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report1
- Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report1
- Gene therapies for sickle cell disease: final evidence report1
- Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report1
- JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report1
- Medications for obesity management: effectiveness and value : final evidence report1
- Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report1
- Tezepelumab for severe asthma: final report1